M1A.2621 Drug-induced chronic gout, left knee, with tophus (tophi)

Name of the Condition

• Drug-Induced Chronic Gout, Left Knee, with Tophus (tophi)

Summary

Drug-induced chronic gout, left knee, with tophus (tophi) is a form of arthritis affecting the left knee joint, resulting from prolonged elevated uric acid levels due to medication use. It leads to recurrent joint inflammation and potential tissue damage, characterized by persistent symptoms and the presence of tophi (urate crystal deposits) in the affected area.

Causes

This condition arises from medications that interfere with uric acid metabolism or excretion, causing accumulation in the blood. Over time, urate crystals deposit in the left knee joint and surrounding tissues, triggering inflammation. Common culprits include diuretics, low-dose aspirin, and certain chemotherapy agents.

Risk Factors

• Use of medications that increase uric acid levels (e.g., diuretics, low-dose aspirin)
• Prolonged exposure to urate-raising drugs
• Pre-existing hyperuricemia or gout history
• Renal impairment affecting drug clearance

Symptoms

• Recurrent episodes of intense left knee pain, often with swelling and redness
• Persistent warmth and tenderness in the affected knee
• Formation of tophi (hard, painless lumps) around the knee joint
• Stiffness and limited range of motion in the left knee
• Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging. Blood tests may show elevated uric acid levels, while joint fluid analysis can identify urate crystals. Imaging studies like X-rays or ultrasound may reveal tophi or joint damage. The presence of tophi and a history of medication use are key diagnostic indicators.

Treatment Options

Treatment focuses on managing uric acid levels and reducing inflammation. Medications may include urate-lowering agents (e.g., allopurinol) and anti-inflammatory drugs (e.g., colchicine or NSAIDs). In some cases, corticosteroids or biologics may be used. Tophi may require surgical removal if they cause pain or functional impairment.

Prognosis and Follow-Up

With proper management, symptoms can be controlled, and joint damage may be minimized. Regular follow-up is essential to monitor uric acid levels and adjust treatment as needed. Untreated or poorly managed cases may lead to progressive joint damage and disability.

Complications

• Chronic joint damage and deformity
• Persistent pain and reduced mobility
• Increased risk of kidney stones or renal impairment
• Infection of tophi if they rupture

Lifestyle & Prevention

• Avoid medications known to raise uric acid levels when possible
• Maintain a balanced diet low in purines (e.g., limit red meat, seafood)
• Stay hydrated to support uric acid excretion
• Limit alcohol consumption, especially beer and spirits
• Engage in regular, low-impact exercise to support joint health

When to Seek Professional Help

Seek medical attention if you experience severe or worsening left knee pain, swelling, or redness, or if tophi become painful or infected. Prompt evaluation is important to prevent long-term joint damage.

Tips for Medical Coders

This code (M1A.2621) specifies drug-induced chronic gout affecting the left knee with tophus (tophi). Documentation should clearly indicate the anatomic site (left knee), the drug-induced etiology, and the presence of tophi. Ensure clinical notes support the chronic nature of the condition and the involvement of tophi for accurate coding.